
GNI Group acquires Ayumi Pharmaceutical for ¥44.8B, boosting its biopharma presence in Japan.
GNI Group has agreed to acquire 100% of Ayumi Pharmaceutical Holdings from shareholders led by Blackstone for about ¥44.8 billion. This acquisition significantly expands GNI's commercial footprint in Japan, especially in pain management and rheumatol...

